Investigational Site Number 032008

Buenos Aires C1428DZF

0 studies enrolling now · 2 studies all time

What they study most

Rheumatoid Arthritis

Studies at this site

• To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET) — Completed
• Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients — Completed